从今日起，“甜蜜”不再是负担

Core Viewpoint - Micro Yuan Synthetic's allulose has received administrative approval from the National Health Commission, making it the first company in China to produce allulose through a biological fermentation process, which is a significant milestone in the synthetic biology industry [1][3]. Company Summary - Micro Yuan Synthetic has developed a unique "one-step fermentation method" for producing allulose, increasing conversion efficiency to 80% and reducing production costs by 50% [3]. - The AS10 strain used in production is described as an "intelligent cell factory" that can be infinitely replicated, promoting the industrial adaptation of engineered strains [3]. - The company aims to make allulose a widely used health sugar, addressing the domestic sugar supply gap while being beneficial for blood sugar control and weight management [1][2]. Industry Summary - The global focus on obesity and diabetes has led the pharmaceutical industry to seek safe sugar alternatives, with allulose being viewed as a promising candidate for large-scale application [2]. - The synthetic biology manufacturing sector is expanding into various fields, including biomedicine, food nutrition, and new materials, with significant policy support from local governments [5][6]. - The innovative production methods in synthetic biology not only enhance efficiency but also contribute to environmental sustainability by reducing land use and production costs [4][6].